Figure 2.

YB-1 is linked to relapse in all subtypes of breast cancer defined by hormone receptors and HER-2 status. Tumor tissue microarrays were stained for YB-1, ER, PR, and HER-2 (n = 2,978 cases in total for all markers). The relative distribution of YB-1 was evaluated in breast cancer subtypes. In all subtypes, the expression of YB-1 was associated with shorter relapse free survival. 'N' represents the number of YB-1 positive patients who had breast cancer relapse (number of events) in each subtype. ER, estrogen receptor; HER, human epidermal growth factor receptor; PR, progesterone receptor; YB-1, Y-box binding protein-1.